Paradoxical psoriasiform inflammatory reaction during the use of tumor necrosis factor-alpha inhibitors in patients with Crohn’s disease (a review of the literature and presentation of two clinical cases)
Psoriasiform rash (paradoxical inflammation) induced by tumor necrosis factor-alpha (TNFα) inhibitors is observed in about 5–10% of patients with inflammatory bowel diseases treated by these genetically engineered agents. Its predictors include gender (mostly female), smoking, h...
Main Authors: | L. S. Kruglova, O. B. Shchukina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2018-11-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/883 |
Similar Items
-
Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
by: Rishab Revankar, et al.
Published: (2023-12-01) -
Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022-12-01) -
Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers
by: Agostino Bucalo, et al.
Published: (2020-10-01) -
Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report
by: Artsiom Klimko, et al.
Published: (2024-01-01) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)